Cold Chain

While all drug development efforts are fraught with peril, a growing number of biopharma companies—large and small—are staking a claim in the rare disease treatment space, chasing odds that could yield clinical and financial rewards

The pandemic, which stressed all participants in the pharma cold chain, has not stopped innovation in industry practices, as exploration of the main drivers shows

Strategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization

Outlining five network-focused ways industry can support cold chain shipping of advanced therapy products

A conversation with dangerous goods expert Jay Johnson

With today's greater combination of technology and know-how, we must design new ways to handle sensitive pharmaceuticals—and do it together

Selecting the appropriate type of temperature-monitoring device starts with understanding the capabilities needed for a specific product

The growing pipeline of cold chain products holds tremendous promise for patients, but can result in failed shipments if not properly planned for

New facility will focus on company’s temperature-controlled pallet shipper rental program

Include frost protection, air flow to protect pharmaceuticals

With integrated supply chain platform, strategic partnership looks to accelerate cell therapy program development

ESG-friendly Crēdo Go expected to benefit the pharma industry

In effort to assist pharma supply chain, company’s end goal is net-zero emissions by 2040

Withstanding fluctuating temperatures along the cold spectrum

Will feature additional cell and gene therapy capacity

Massachusetts facility will support biologics developers in the New England area

Illinois branch makes it the company's sixth new location in 2022

Company’s 344,000 square-foot facility revolves around pharma and medical items

Ultra low-temperature freezers continue to change the game in cold chain

In deal to be finalized by October, purchases B Medical Systems for $423 million

Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity

With the use of mRNA vaccines on the rise, so is the need for dedicated freezing and storing solutions

Acquisition of healthcare logistics company to play a role in delivery of pharma and biologic treatments

Cold chain logistics deal expands business’ international reach

Partnership allows for distribution of packager’s temperature-controlled container

Will serve as a hub, as company aims for growth in the European region

Transaction totals about $3 billion

Deal expands CDMO’s presence in Europe

How can pharma manufacturers and distributors balance logistical demands and environmental impact?

Company anticipating to double global network size by end of the year